Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Initiates Coverage On ShockWave Medical with Buy Rating, Announces Price Target of $240

Needham analyst Mike Matson initiates coverage on ShockWave Medical (NASDAQ:SWAV) with a Buy rating and announces Price Target of $240.

byBenzinga Newsdesk

March 15, 2023

1 minute read

Needham analyst Mike Matson initiates coverage on ShockWave Medical (NASDAQ:SWAV) with a Buy rating and announces Price Target of $240.

DISH Network’s SLING TV Is Now Available On VIZIO SmartCast

By Benzinga Newsdesk

Today, 5:25 PM

VIZIO today announced that SLING TV, a leading streaming service delivering the most popular live news, sports entertainment and kids programming, is now available on VIZIO SmartCast TVs. This press release

DISH

News

U.S. CDC Says Risk Of Myocarditis With ACAM2000 Smallpox Vaccine, No Myocarditis Reported In Association With Jynneos

By Benzinga Newsdesk

Today, 5:25 PM

-Reuters

SNY

Stifel Maintains Buy on Xylem, Lowers Price Target to $103

By Benzinga Newsdesk

Today, 5:25 PM

Stifel analyst Nathan Jones maintains Xylem (NYSE:XYL) with a Buy and lowers the price target from $105 to $103.

XYL

Analyst Ratings

Where IsoPlexis Stands With Analysts

By Benzinga Insights

Today, 5:25 PM

Over the past 3 months, 5 analysts have published their opinion on IsoPlexis (NASDAQ:ISO) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

ISO

Needham Initiates Coverage On ShockWave Medical with Buy Rating, Announces Price Target of $240

Related Posts

DISH Network’s SLING TV Is Now Available On VIZIO SmartCast

U.S. CDC Says Risk Of Myocarditis With ACAM2000 Smallpox Vaccine, No Myocarditis Reported In Association With Jynneos

Stifel Maintains Buy on Xylem, Lowers Price Target to $103

Where IsoPlexis Stands With Analysts